Thread on Astec Lifesciences Ltd 🧵
Market cap: 1996.7 crores.
Revenues: 522.61 crores.
P/E: 27.62
P/B: 7.0
ROCE: 20.44%
ROE: 21.24%
Here we go👇
ASTEL is a niche chemical company focused on triazole fungicides & on proprietary off-patent products in the CRAMS segment;
1/25
New products in the herbicides segment should drive growth in the CRAMS space.
Leader in triazole fungicides:
Tebuconazole and Propiconazole currently form a major part of ASTEL’s enterprise business while it is capable of venturing into newer products given strong
2/25
technical knowledge in triazole chemistry.
Newer mixtures/geographies to drive growth in Enterprise business:
Triazole fungicides have been losing market share over the years as new products (SDHI fungicides) have proved to be a replacement;
3/25
However, with a few SDHI (succinate dehydrogenase inhibitors) products facing resistance in some geographies and given strong forecasts for this segment, triazole fungicides are likely to benefit–albeit in a limited way–from their inclusion in a
4/25
mixture of products (with some SDHIs).
ASTEL is setting up a new herbicide plant To diversify its product concentration from the triazole fungicide segment.
New R&D Centre to aid diversification:
Would help develop new processes into various chemistries like fluorine;
5/25